A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With “Long‐Covid‐19”

ABSTRACT Bufei huoxue capsules (BFHX), manufactured products of traditional Chinese medicine, have demonstrated anti‐inflammatory properties and efficacy against chronic pulmonary diseases and COVID‐19. This study was designed to further determine the clinical efficacy of BFHX in diverse patient sub...

Description complète

Détails bibliographiques

Auteurs principaux:	Chi Hou, Yue Xing, Yuqin Chen, Tingping Wang, Jingjing Qi, Xiaoqing Jia, Xiansheng Zeng, Jianling Bai, Wenju Lu, Yu Deng, Bihua Zhong, Yongxia Lei, Yilin Chen, Zhan Lian, Haohao Zhou, Junping Yan, Xuejiao Yang, Hao Yu, Jiawei Zhou, Lixia Qiu, Yunliang Zhai, Wanli Geng, Nanshan Zhong, Chunli Liu, Jian Wang
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2025-04-01
Collection:	Pulmonary Circulation
Sujets:	bufei huoxue capsules post‐acute COVID‐19 syndrome subgroup reanalysis symptom recovery traditional Chinese medicine
Accès en ligne:	https://doi.org/10.1002/pul2.70084
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!